검색어를 입력하세요.
[의료] |
(항생제) 심장초음파 데이터 경흉부/경식도 심장초음파 데이터
|
데이터 기본 이용료
|
데이터등록일 | 데이터 수정일 | 데이터 이용기한 | 판매제공처 |
---|---|---|---|
2023-11-30 | 2023-12-06 | 무기한 | 용인시산업진흥원 |
데이터 제공포맷 | 데이터 제공방식 | 데이터 파일용량 | 데이터 상품구분 |
csv/zip | 다운로드 | 22.08 MB | dataset |
본 데이터는 국내 종합병원에서 19XX년부터 202X년까지 항생제를 처방받은 입원, 외래 환자에 대한 모든 정보를 익명화하여 제공합니다. [데이터 범위] 항생제를 처방받은 입원 환자의 심장초음파 (경흉부,경식도) 판독 소견 [참고 데이터명] 치료결과, 환자 바탕질환 데이터, 항생제 처방 전후의 생징후 데이터, 검사실 소견 데이터, 혈액 및 검체 배양검사 결과, 처방약 데이터, 카테터 데이터, 폐기능 데이터, 심전도 데이터
등록번호
|
내원번호
|
처방명
|
시행일자
|
소견내용
|
||||
---|---|---|---|---|---|---|---|---|
0x2e7cc3a159fdd565bcbd694c375110131eb38bd9ff9ba698543e02e78fc9fe63 | 0x91e5b2816789048633fa83130f0135a8319370dc07677c8b24f97ebf24295acf | 경흉부심장초음파 (단순) | 20880619 | * Compared with previous echo: 2020.11.13 - AV: calcfied and opening limitation of 3 cusps with moderate AS and mild eccentric AR ; no significant interval change (Vmax 3.2→3.2m/s | peak/mean PG 42/22→42/22.5mmHg | AVA by C.E 1.3→1.3cm² | 1.56cm² by PR | Zva 2.6) |
0x935d1292c36344028f6ac477af147a6d780b4bf5b92f3ac7a64db508884eac74 | 0xa3bfc56dd3e4773d4dcf82bc181c4e4f221a69c7a3b62712bb2619f11b41a4e1 | 경흉부심장초음파 (전문) | 20421115 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : s/p AC#4 (2021-09-24) | 금일 Herceptin #1 예정. 3. Date of Baseline TTE (2021-07-16) 4. Baseline LVEF : 63% | |||
0x56bc9c5f8a028cf6551b172e02ba19d1e6b63dd41f4059583fd821817b0a0d34 | 0x4bcfa3a095939a9fcf2b4bf64902b79c3ddb14b16b0e2a4a8da48c7dceb854c5 | 경흉부심장초음파 (단순) | 20500603 | * Previous study: 2021-02-22. 1. Normal biventricular systolic function by visual estimation. 2. Rheumatic moderate MS (MV area 1.4 cm2 by 2D planimetry) 3. Decreased echogenic mass (19.7x12.4 ->12.2x8.8mm) in LAA; c/w thrombus. | ||||
0xcd462afc3f6b3cf3a427af2f9de1ba7f0e811cf6b01ad3577d97b087e094f2e6 | 0xa933a49026a60ae312f7ac005b7c149b94222c46bc795f06dc8b71f4732e9c67 | 경흉부심장초음파 (전문) | 20310109 | ============================================ 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : 2021-12-31 Herceptin #16 3. Date of Baseline TTE (2020-08-24) 4. Baseline LVEF : 65% 5. Baseline average LV-GLS : -18.0% ========= | ||||
0x70cdb74c646877ebbd6fd15f135062fb2245e5324fbe01ce42209765ba052836 | 0xf572d520fdac4baca8c22fa7399a15046282e296cfb58a8957cb081331b83ccf | 경흉부심장초음파 (전문) | 20861226 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=55%) 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | ||||
0xd2ac2a2f515e250823732b4b5b990fe349ed9f2cfa3f75edf57916508578d238 | 0xf792357dc3bc3e39853c6f6a3ad746b5b8c5603542bb5dd93a419888ab24830b | 경흉부심장초음파 (전문) | 20370327 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=55%) 3. Normal LV diastolic function (E/e`= 6.2) 4. Valves: normal morphology and function | Trivial TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | |||
0x19fc492826fb98eea32a5487692396bccf4a2f9cf99acc1fc9697c292fdf809b | 0x969d577d4f6f2070198d679b9a9ab716527ddf19fe502acfd3203f602b958dc3 | 경흉부심장초음파 (전문) | 20600415 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : 2022-11-16 Taxotere 3. Date of Baseline TTE (2022-08-02) 4. Baseline LVEF : 56% 5. Baseline average LV- | ||||
0x312431df002fbfd736471f4d781b7051c8c129d38bf26873e5d958559c49d5fa | 0x6718308cca155aea3bf34416f123f3426a6ab2ce12f50fe93ce869e543207ed0 | 경흉부심장초음파 (전문) | 20910329 | -STEMI | CAD(1VD) | patent mLAD stent | 2016- 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=65%) - Normal RV contractility 3. Normal LV diastolic function 4. Valves: normal morphology and trivial T | |
0x55566d7a282294b4b1b991c87cb33a2d20a44455b05a33171f1244362397034d | 0xb86e10e04c2a7062ec0c793be8f3890f6032bc201a95e0b58e7bbd7233d4f5df | 경흉부심장초음파 (전문) | 20480225 | -Partial DVT - ** poor echo window 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=59%) -Normal RV contractility 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No re | ||||
0x3febabab42bcb072aa353a443a6e641c9b7a6bc59f01447026ab11c1d4d60d10 | 0x7a99fdd6e6ba504747ac823d19b0700a94ec376358a69f79fa2ca40d1ade01c7 | 경흉부심장초음파 (전문 | 선천성) | 21120331 | -situs solotus- 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=59%) 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardia | |||
0x7f9aa7d0cea12667f4c3c4d3a37d70cc0dccd2f64584d1ec6a4add809276ac68 | 0x7288496010bc378147877cad7639de183de61023507caef742d49a223ea3cb85 | 경흉부심장초음파 (전문) | 21081210 | -compared with previous echo 2018- 1. No interval change of dilated LV dimension with normal LV wall thickness 2. Global hypokinesia and reduced LV systolic function (EF 34->34 %by volume) -Normal RV contractility 3. Grade I LV diastolic dysfunction (E/ | ||||
0x42eb605bd1f10d756326156f20860131ac3196aef1dc2b8ef211f87d55633e60 | 0xe0581f5317714bdae17d3a6874506776296fb42fc5b3a828dbd08dbcbd909207 | 경흉부심장초음파 (단순) | 20210701 | <단순심초음파> * Sinus tachycardia * 1. Normal LA size 2. Normal LV diastolic function (E/E'=11.3) | Visually normal LV systolic function 3. No resting pulmonary hypertension. | |||
0x895a3930f510a47bc63cf581a3e4eaaf9d419fdb8a9372f3ff6c72db914a945a | 0x1f205baa583ced222a3bd42daed58bdd776386ce738e85a9e155bb0b9000e21c | 경흉부심장초음파 (전문) | 20261227 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=63%) 3. Normal LV diastolic function (E/e`=8.2 ) 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc.) Normal LV systolic function (EF=63%) | ||||
0x81ed96d851e0f83a643c28db67e39b5f8b4de277e0a8e4d488f52ce7a5494c53 | 0x3b064e16b0603ebb2724abd676b7b06cb513ec0c9fda2110421f4a991637b59f | 경흉부심장초음파 (단순) | 21120808 | 1. Relatively small LV with thickened LV wall; No significant change of cardiac size 2. Slightly increased pericardial effusion compared with previous study (small→small). | ||||
0x1138dc7dde69ac707cc9dd8cc6809caf2201b58881cfab8f2f0c506543d45750 | 0x1b7225cca52308d79f52a64dd3a99f6c201f98d77cea7bdee6fb6aaddf8da1a0 | 경흉부심장초음파 (전문) | 20771128 | =========== breast ca. /total mastectomy -> AC -> paclitaxel =========== 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=62% by Simpson's method) - Normal RV contractility 3. Normal LV diastolic f | ||||
0xfe99854c472bc923d91b77dd03d400d3247660b40e15daf63daed32208fc650c | 0x2de2ccfdf4ead879e8054a294ca10697ae8bb9aa39c4b48df6a86c6dfa6f024c | 경흉부심장초음파 (전문) | 20561010 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=65%) 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal LV systolic function without RWMA | ||||
0x77b229c68622f5a5bad3b53735f86bd09072d79034607703ac1f5c565cf54c1c | 0x2a686ed992e0003fa74ec86eb6fc247b41e4f39d45e610e1db08e6fad7f5823e | 경흉부심장초음파 (전문) | 20980125 | ----------------------------------------------------------------------- 1. Type of cancer : Ovarian ca. 2. Types of chemotherapy / the number of cycle : Baseline TTE 3. Date of Baseline TTE (2021-07-29) 4. Baseline LVEF : 57% 5. Baseline average LV-GLS : | ||||
0x534d0d93a4cbfe23695767e124dd841550f06aabf7a31b64f26b8945a7448554 | 0x3e1efb4fd956090d8864a1336dcd0d4ef1c0470008b84a6bffd8319bbaaf7cda | 경흉부심장초음파 (전문) | 20440924 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=67%) 3. Normal LV diastolic function 4. Valves: normal morphology | trivial TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal cardiac dimension and normal LV systolic function | |||
0x521bebe45042d26a6ad5d2e551371756215fb0bc4c5136b0e1b96d2107143379 | 0x078d183cdbdb1f1ebcb6c8c4fca654e827eb5c597d6cdcea8448af8907391dc9 | 경흉부심장초음파 (전문) | 20450305 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle: Baseline TTE 3. Date of Baseline TTE (2022-07-22) 4. Baseline LVEF : 62% 5. Baseline average LV-GLS : -1 | ||||
0x3f410b776ea1b5433e8aa8cf93ac6d7351a868274ab94db52369578c307ada90 | 0x5357e824c58abb2eb3715f307279f888bb4251d7b9f1a5db3462fad699ad1f64 | 경흉부심장초음파 (전문) | 21110223 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=67%) 3. Normal LV diastolic functio (E/e`=7.8) 4. Valves: normal morphology and function | trivial TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc.) Normal LV systolic function (EF=67%) | |||
0xc095f12dc9e5e710701aa5d7ca6487eb001cb5db499d9dce8e1c4f67b889e87a | 0xd8c7a82dbc369b2942c8f55afad262551bf0fb694319295954388bbf11f21924 | 경흉부심장초음파 (전문) | 21080218 | ---------------------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : #11 HP 2022.03.07 3. Date of Baseline TTE (2021-07-09 | SMC) 4. Baseline LVEF : 57% by Simpso | |||
0x26a8ed8acf7bd2d4e6b994362419bbdafc3fd853def2f2631ddc9c659683a86d | 0x52bbf73df68a15882651363c53b710400db49ca110d9d827d39b9beedad85923 | 경흉부심장초음파 (전문) | 20771224 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : s/p Adjuvant AC CTx #4 (2022.01.25~2022.04.12) wPaclitaxel CTx #12 (2022.05.04~2022.07.22) | RT 예정. 3. D | |||
0xef68ddffe911c8b7ebb366ce3488851d716c082ec4b0bb93cbdec1d90c6882fb | 0x85b5724b01640f8dc66a2041dad845aa17517097ce3b66549abd29a12c6a5055 | 경흉부심장초음파 (전문) | 20561123 | ----------------------------------------------------------------------- 1. Type of cancer : DLBCL 2. Types of chemotherapy / the number of cycle : Baseline TTE | R-CHOP CTx 예정임. 3. Date of Baseline TTE (2022.08.01) 4. Baseline LVEF : 60% 5. Baseline averag | |||
0xbdaba5a49b098f408f0833582199da656a0e1414f882bc84bf873977f12e5bbe | 0x8ac6f7986ae6fcb9565563166a6670184bb880c838ac6548e284c139683028fc | 경흉부심장초음파 (단순) | 21020806 | * Frequent APCs’(HR : 92bpm) * 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=60%) 3. Trivial TR and No resting pulmonary hypertension. (RVSP=38.6->34.1mmHg) 4. No pericardial effusion. | ||||
0x86c2e627ce84c105539a50b85e73070fe6bbcdb4c0d5af1700ebdd33602ff9d9 | 0xddeb2c0b87a3886f82f26a3c0c122954423d7e9fd7e88b9fdc5c88ec19d59cea | 경흉부심장초음파 (일반) | 20230705 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=67%) 3. Normal LV diastolic function (E/e`=6.0) 4. Valves: normal morphology and function. Trivial MR and TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | ||||
0x698e4615f33d77fb09ff08627720145c16c587b0fd2b2e34384cfe24202ec40c | 0x80401a25851bc8fe7eccce369c6c56d7928e78d6d3522790af3652973302aa0f | 경흉부심장초음파 (전문) | 20781107 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : Baseline TTE 3. Date of Baseline TTE (2022.08.16) 4. Baseline LVEF : 60% 5. Baseline average LV-GLS : - | ||||
0x8e05bee08d2c262667b7d435dc12fc6c645fedc759fdfafb8bfb0963bd44ec1d | 0xdafacb8fe8330ca2539aaf90806b87feefb46f2b69ad255b2623b000f9f6a0e9 | 경흉부심장초음파 (전문) | 20360121 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : Baseline TTE 3. Date of Baseline TTE (2022.08.17) 4. Baseline LVEF : 59% 5. Baseline average LV-GLS : - | ||||
0x360127bf66ec1201a3946567faa15444165f15ca14bf44b36f19968b91eca959 | 0x3ef04529c6fd93f9a2cc5901dc1a598cdcb264a0681652280c87a38c09d6360f | 경흉부심장초음파 (전문) | 21000116 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : S/P RT from Jul 21 ~ Aug 10 | 2022 3. Date of Baseline : Baseline TTE없음 (타병원 검사) 4. Baseline LVEF : 5. B | |||
0x198cbd70dd21925ca4cc340a046ff0742a0b78cc21b15f445288b3c1196d05fd | 0x6f0cd9faaca06b9181cd79c1f0179c5682f7d91b69ad543ec0b571092dd099e7 | 경흉부심장초음파 (전문) | 20590413 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : f/b wTaxol 3. Date of Baseline TTE (2022-05-30) 4. Baseline LVEF : 64% by Simspson's method 5. Baseline | ||||
0xdcad7dc4b91f4b9ea75ae45b0125326f1a66eb6697c3b87f9c912f0818f25042 | 0x7a62fd2c1fe0734002186c919e7906dcdde333a7403f18cae4be0c8aeb8b7b37 | 경흉부심장초음파 (전문) | 20530714 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : Baseline TTE 3. Date of Baseline TTE (2022.03.07) 4. Baseline LVEF : 62% 5. Baseline average LV-GLS : - | ||||
0x41dcb222bb48257084f0cb18499bd8a51849cce5c0867f730e08a8d3d1537e6c | 0x1909f1fde8fe206833b4b711a1dd20bb1c42cd76fd24addaf31c5a6f82cffc3d | 경흉부심장초음파 (단순) | 21161104 | * Compared with previous echo : 2022.06.07 * s/p PCI with ZES for dRCA lesion & DCB for os-to-pLCx (ISR) :2022.06.09 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=61→61%) 3. Dilated ascending aorta (41.8→41.6mm) | ||||
0xb2a7ec72d26f7f50aa6dbb68698fd8ac5104a9a1fd8e9168430ce581b0b65af1 | 0x25b7f386f5ef92fbe2c54d4c024d828a0dd7f0d6a31e8010cdec245d5105788e | 경흉부심장초음파 (전문) | 20860712 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=60%) 3. Normal LV diastolic function 4. Valves: normal morphology and trivial TR 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal cardiac dimension and normal LV systolic function | ||||
0xdb53c12ccdc7bdebd43574414f7db2cc492708696033e3498869942d9c361150 | 0x71355fc672f8bb1c281adcb3c598b143533e68e60cc2eeaab8f17cfe0eca1b18 | 경흉부심장초음파 (전문) | 20490926 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=65%) 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc.) Normal LV systolic function (EF=65%) without RWMA | ||||
0x9b6b2f55c1405f80f3de787e9f56db08eceaccc4c6d54f80bece92e865e68af1 | 0xe50ea9b2204e101a0ca9bc567136f08eb34a8fea35c3b86992bccb856d7c778e | 경흉부심장초음파 (전문) | 20530404 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=58%) 3. Normal LV diastolic function (E/e`=7.1) 4. Valves: normal morphology and function. Trivial MR and TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | ||||
0xbb60443c4b4536e0d687b81dfea241fbcaa0bd8803e831b93ed51b92bb2c81ea | 0x5ab4088766c8b54a420b8761cb2a69addc1ee78482dbbac8b701119c20b5f8c9 | 경흉부심장초음파 (전문) | 21001127 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : #1 AC CTx 예정 s/p Neoadj. TCHP 6cycle 3. | ||||
0xe66126b3b9e9ae1c8536408a9de0dc6de1f507c7072d49563a1e1a7bc35d3ac2 | 0x69bf62339ea57e4591d4cdda2a3d9c5544e71c8e0f0eb85ef7827fede1adfa2c | 경흉부심장초음파 (전문) | 20550914 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : #8 herceptin (2022.09.07) s/p 4-3 wTaxol+Herzuma on 2022.04.04 3. Date of Baseline TTE (2021-12-15) | ||||
0x314ce0c363c21b507c042531316efb806a7c39bde03be6c9e561f44d0b50b526 | 0xfc3db2107362d8d367251d57c3dd606b12857062a8b2b6a9300d3c88032de68a | 경흉부심장초음파 (전문) | 20930814 | ---------------------------------------------------------------------- 1. Type of cancer : Small cell lung cancer(extensive) | LN | bone | liver | r/o brain matastasis 2. Types of chemotherapy / the number of cycle : Irrinotecan/cisplatin 2022.12.9 / 4th 예정 |
0xbda73755ec3e1fcb277b09856cdfb45c1e2b3895e79679ac5b839e744c997cb0 | 0x96f454ed9c66453f2b8658544d4b502bf7e7be80ffe3cd00a041c4048ff2e050 | 경흉부심장초음파 (전문) | 21020531 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : Baseline TTE 3. Date of Baseline TTE (2020-09-17) 4. Baseline LVEF : 60% 5. Baseline average LV-GLS : - | ||||
0xdc9cdb5e429e2dad1c545a9277ac140fdc51f48b2213051347dfab96aa66030b | 0x33e07dfcbe85866e3711839d34dd4db5213875b6db648f439dfb34feda08a014 | 경흉부심장초음파 (단순) | 20510310 | Small pericaridal effusion (LV posterior side: 7mm | RV anterior : 7mm | LV lateral : 6.8 mm ) | ||
0xc6dc8ec776e11ad4b7df1bec053375463be51248e5a6d6623aad3a871ed1ffb5 | 0x413e1b462196013ce384c952f9ac0a09af8a0dbf7c93b6092717fe01ef63ae35 | 경흉부심장초음파 (일반) | 21150210 | 1. Enlarged LA with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=57%) 3. Normal LV diastolic function (E/e`= 6.1) 4. Senile sclerotic AV with trivial AR 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Enlarged LA and normal LV systolic function | ||||
0xcd1815d1218eff498fff29f99c5f5ec20b1ad3916349c83f0c471266fea48b62 | 0x9719bd7a98e545d39fd3dc5b6d0cf2d354f2dbadea91c6fbe5e87c67ed05ba81 | 경흉부심장초음파 (전문) | 20290122 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=54%) 3. Normal LV diastolic function (E/e`=6.7) 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | ||||
0x7d136f8d8bf81146421fd87be6cd524610ac2e4a420000a642aeaa0ab4aad505 | 0xe3a70e6f8a26f3acff81803a9d0de2c73aea5b54ceb9224ec5adc4d2d85e2296 | 경흉부심장초음파 (전문) | 21040811 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=64%) 3. Normal LV diastolic function (E/e`=6.0 ) 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | ||||
0xe66efa2d182de4d24bf6827a05ff6f777d0f3e55dee6c21b16c6cd8a5d1272ac | 0x7647ed6dddccaae826a27eb956923801a2fe9c7233d294c797ce8e9ade88df50 | 경흉부심장초음파 (전문) | 20530816 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=65%) 3. Normal LV diastolic function 4. Valves: normal morphology and trivial TR 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | ||||
0x8c2864c2ac5abfc906976941f01b23033cc9fbd6a7d3e40260cf2ae1b5d5fe1c | 0x5e3f58ac82241d2abceff67fc1c572050932cd0678a366ef47169c31b770e45c | 경흉부심장초음파 (단순) | 20310917 | compred with previous echo : 2020.12.04 1. Mild pulmonary HTN (RVSP=72.2->36.3mmHg) 2. Normalized TR (moderate -> trivial) 3. Normalized RV and RA sized Conc.) Normalized RV and RV size with mild resting pulmonary hypertension (improved) | ||||
0x341be2c5021f6a7b9db6d8c3eb0499163db68026bdd9a78523ddac6ba8c6c332 | 0xdbe1c0cd9382a6aaa24dbd5a0a51c3734219e06038c19eed98af82c81d25a7f4 | 경흉부심장초음파 (전문) | 20950422 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=61%) 3. Normal LV diastolic function (E/e`=5.8 ) 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | ||||
0x48d871219431180022c279df7fea725bbe685337cc83c1a74394507e0847c6d2 | 0x3e733d088646d735ecb7841a50c598fa850ec7d9c202b929502d3122d0c3f6ba | 경흉부심장초음파 (전문) | 20291223 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=70%) 3. Normal LV diastolic function (E/e`=7.1) 4. Valves: normal morphology and function. Trivial TR 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | ||||
0xf749d1597ab44b1b75fded00f7aee4526494f9eab4645e655f1132a6560b9129 | 0xc64aa1d225b00cfe3f574c92bf4c9a17c72c58180c5b18fccec5a03a4b24fa73 | 경흉부심장초음파 (전문) | 20560608 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : s/p 5th HPT CTx. 3. Date of Baseline TTE (2020-09-11) 4. Baseline LVEF : 66% 5. Baseline average LV-GLS | ||||
0xb41e009e6c31508e76663a679815a59169f9197158fc623a2b095bb7a6e86280 | 0x162c8f284e64439a093c5d7e6177a9cc0e961e59c5fcbc8cb1b423d9d653cbd6 | 경흉부심장초음파 (전문) | 20880905 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=65%) 3. Normal LV diastolic function (E/e`=6.7) 4. Valves: normal morphology and function. Trivial TR 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | ||||
0x626e1e6799dbedb290b41f11c93c14030cf3105816abf6fa49f1847a594e3cc8 | 0x253b436f416a15365fc2779ad53dd63ee751ece1a43e7b8da8c89364757174a0 | 경흉부심장초음파 (전문) | 20671123 | -ppor echo window- 1. Enlarged LA(LAVi=34.5mL/m²) with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=66%) - Normal RV contractility 3. Grade II LV diastolic dysfunction (E/e`=16.4) - LA reservoir strain of 18% on A4ch 4. Valves | ||||
0xb2872750b1bdd6eba774b2823dc33c4a73373f73672507f60cf2667fe3cca0f3 | 0xf6b0265d0402065d9688a7817315e9fc71bbc1ac7122490c1546152b1f2cd7f0 | 경흉부심장초음파 (단순) | 20861223 | * Compared with previous echo: 2020.03.03 * 단순심초음파 1. Dilated both atria 2. No RWMA and normal LV systolic function (EF=60%) - Normal RV contractility 3. Loss of A wave d/t A. fibrillation (E/e`=14.3->18.1) | ||||
0xdd7a0ec118dc68f452a3d38b3152d45ca9709598536653418d54ce67d58e60ef | 0x8d9ddeba08bc085f45d9d1f9e972dedf54fc668021aca226f35f93b300a6f062 | 경흉부심장초음파 (전문) | 20520526 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=63%) 3. Normal LV diastolic function (E/e`=7.0 ) 4. Valves: normal morphology and function | trivial MR 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | |||
0x6a3ed3158cacf16169a80e5dc544fbe265d9337fc2d1b8ab71949f347214cab1 | 0xb0e3e003a5fcd6788f6ddbe1c356c9aae4d41af2a5e031f010c9017e5d043d8f | 경흉부심장초음파 (전문) | 20771104 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=68%) 3. Normal LV diastolic function 4. Valves: normal morphology and trivial TR 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal LV systolic functio without RWMA | ||||
0xf6b292c55ad9eef28722e5e99c1db530ca84dfcc503840db7c53ba4d96d11b8d | 0x052c7a0d2158a0cb1cf48ff6aeda3053e1597b5806c7e8735335f225a437d59f | 경흉부심장초음파 (전문) | 20551227 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=57%) 3. Normal LV diastolic function (E/e`=8.4 ) 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | ||||
0x6e61a7b31f10d439693a0b4bfd11ad220abc69157737c3a58409abf5260c6141 | 0xa5b4ffc819811f001ef63216b1406a9e1e6fdd51a2836e38c3be760eea8ed6de | 경흉부심장초음파 (전문) | 20850916 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : s/p #6 adj. Herceptin sq 2022.04.11 3. Date of Baseline TTE : 2021.09.23 4. Baseline LVEF : 63% 5. Base | ||||
0x0db83e200abb6ef1a75d8511aa05850e5f8cc6c31dea5803cefe596a88a034da | 0x7f392a9532ea7e10e21549d387be1c2285ee9e44a28d979c9aff30a349a9ca06 | 경흉부심장초음파 (전문) | 20290204 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : Herceptin SC mon 3. Date of Baseline TTE (2022.02.09) 4. Baseline LVEF : 60% 5. Baseline average LV-GLS | ||||
0xd98b017a605540d3f35982a3bcb2786a856fc1b75cb3cc265eea646a385036df | 0xaa2ac632bfc84dcfa38d5e1718403d7da7855c60ea0b7c4029c5561335460c38 | 경흉부심장초음파 (전문) | 20490530 | ---------------------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : #4 neo TCHP CTx 3. Date of Baseline TTE (2022.08.12) 4. Baseline LVEF : 60% 5. Baseline aver | ||||
0x20700dc5cfe85b305be1900509fb1601aa637b026dfae2f1966a0cb20baece4b | 0xa8597bdd674d718a7f5a35528a8b39893685ee375a5d30a5728fe4d4f76d6791 | 경흉부심장초음파 (전문) | 20671130 | -poor echo window- 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=56%) -Normal RV contractility 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No resting pulmonary | ||||
0xd98a763e115937cda5475d0af94539ec810b4d455cf40ccd729470a2cb8501c0 | 0x23a7032486117924b3d5cc4742a6166ae08753f4801c77b7f48e4c2c75895ffe | 경흉부심장초음파 (전문) | 20470710 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=63%) - Normal RV contractility 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conclusion) Normal Echocardiography | ||||
0xbee6ef85a015734924d31ad290eceb4b9bc43a01675b3db14741524383bbfcce | 0x025eeac3d03e0a5362ad1e75ba5391c160200d0c7caa632fbb9c33f2040e7ec7 | 경흉부심장초음파 (전문) | 21060428 | -------------------------------------------------------------------------------------------- 1. Type of cancer: Breast ca. 2. Types of chemotherapy / the number of cycle: #22 pall HP (222.07.11) 3. Date of Baseline TTE (2020-08-08) 4. Baseline LVEF: 65% 5 | ||||
0x6346ae115e4248ff64cf92fa3f704a056c13af3b0353ca1e16a59e47251fefc5 | 0x4cf97b8553b6abf46a7f42fa4bf73c9ef5fb18479de22594e51e06f9fde1e979 | 경흉부심장초음파 (전문) | 20700125 | ---------------------------------------------------------------------------------- 1. Type of cancer : MDS-SLD 2. Types of chemotherapy / the number of cycle : s/p 20th VIDAZA CTx (2022.02.21) => 치료 종료 3. Date of Baseline TTE (2020-05-26) 4. Baseline LVEF | ||||
0x96dd32054ce32c121731e1486985d0ae5a5f938606de6afbdb964b68451d0a68 | 0x23703d76077ea57ba42546e837632c4e2bac308e942dfc9ddfa514b35f1836ef | 경흉부심장초음파 (전문) | 20490219 | ---------------------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : Baseline TTE 3. Date of Baseline TTE ; 2022.1.19 4. Baseline LVEF : 67% 5. Baseline average | ||||
0xd85a6a3622c2fe11d99725e79b22b568481e4a796246425344b81993319ccb4b | 0x05604bb23124a6d2f3303d97c666c74898c786c43c057ee47b3309591b65857e | 경흉부심장초음파 (전문) | 20450130 | 1. Normal cardiac dimensions and LV wall thickness. 2. No RWMA and normal LV systolic function (EF= 70%) 3. Diastolic dysfunction G I (E/E` septal=11.4) 4. Valves: Grossly normal morphology and function. 5. No resting pulmonary hypertnesion. Conc) Normal LV systolic function without RWMA. | ||||
0x0d10a215fca3512821f463847312966732cfad2ced1721d1105a74181e5a4475 | 0x5f4daa4f123760259fbe365cbc32839491eccbb7258e1a37a05377d9d7570973 | 경흉부심장초음파 (전문) | 21120520 | 1. LA enlargement 2. No RWMA with normal LV systolic function (EF=60%) 3. Loss of A wave d/t A. fibrillation (septal E/e'=10.1) 4. Trivial MR | Trivial AR 5. No resting pulmonary hypertension. 6. No Pericardial effusion. Conc) Enlarged LA and normal LV systolic function. | |||
0x576cfe44e613970380e4558a8fe0b6f88473e3395348f1d63b52679aeec7540c | 0xef3ab943bf18933c8d70bf57ebd0f7f56aa5b146255e813acd0aca4ec04796c1 | 경흉부심장초음파 (전문) | 20500611 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=60%) 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No visible thrombi in LA and LAA | No pericardial effusion. Conc) Normal Echocardiography. | |||
0xfc08ac170471addcd1ce40a0b090e659cee0d9f7e5655480e168460a4652efcb | 0x79badd3eee6b480785931cce3205419f768306c990e1aec968cbbfaad30d039b | 경흉부심장초음파 (전문) | 20560425 | 1. Normal sized cardiac chambers with normal LV wall thickness 2. No RWMA with normal LV systolic function (EF=63%). 3. Normal LV diastolinc function (septal E/e'=5.6). 4. Normal valvular function and morphology 5. No resting pulmonary hypertension 6. No pericardial effusion Conc.) Normal echocardiography | ||||
0xb5c69eae77ac3bf49a573f3a6f63b16c8194e98a5682f38f83c8218c459ac0a1 | 0x61045f4a3abd79b69bb1079256842e797c55bbcccf9fe76532659bf8b284ce4e | 경흉부심장초음파 (전문) | 20900810 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=67%) 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal LV systolic function without RWMA. | ||||
0x94d659bf002ef46976aeb1f7ee973c9a1ab788cae5db51d8645254ef20f6fd80 | 0x9c5678a8aff3f977655fadca5a96f738a4d09c5aeb7790a896da2244eb4befd3 | 경흉부심장초음파 (전문) | 20430601 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=55%) 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion | Chiari network in RA. Conc) Normal Echocardiography. | |||
0xa04e303a77c9ac9f03433bc773fef078acd3360e03e48bdde512f651224f09d6 | 0xa7430e2e2798d3d7d20e808e97f4adfe6696025e6e04a77295d85cd8faee1775 | 경흉부심장초음파 (전문) | 20591111 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=72%) 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc.) Normal LV systolic function (EF=72%) | ||||
0x4ac6d9149fb49f2f79ff1c18cbc6bc55d78c8bfc601ee428320bd61872d610e2 | 0x9e2a4c250ad6c81ac800045f936a8e76b42aa46af34868a2549b8179aa99a76f | 경흉부심장초음파 (전문) | 20320504 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=64% by Simpson's method) 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography. | ||||
0x533f651330837ee3d8f7bd95ea15c1e19cfdadcc0f2a2b587c2aa97648b3c937 | 0xe7157fa0048d2f7234abfd153e02a2387230a7e0f3875220374356805ebaf21e | 경흉부심장초음파 (전문) | 20451027 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : Baseline TTE 3. Date of Baseline TTE (2021-07-27) 4. Baseline LVEF : 69% 5. Baseline average LV-GLS : - | ||||
0xf40a78d4921db7a4577cdb965b2d12d3260e4e810d4b18fe0ecbb0054efc9cdb | 0x4aa3528e7e7f8393c6c32dce7b0933d713d1e23776fbb70da98b05dc270bdc06 | 경흉부심장초음파 (전문) | 20550316 | -Compared with previous echo(2013-08-26)- 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=69%) 3. Normal LV diastolic function (E/e`=13.9 ) 4. Valves: normal morphology and function. 5. No resting | ||||
0x98df00b7a7e620872ed01f0a41eebcf48cf8b0309a6d15303a633fad3039aa70 | 0xced0ae1a68c2f4320dff2fd2deb00cc7eb33343847435fd247650d9cb6b368fc | 경흉부심장초음파 (전문) | 20500720 | -------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : Neoaj TCHP#6 - OP - RT/ET/Herceptin+Perzeta#12 on adjuv | ||||
0xd7541c3680adddca98e0006a983dd06f60d14fa7b95c276c1a8b7f0eeeb38687 | 0xcd8a6aea1d303009f1f43282b5f7b47c8f679d55ea09fa02a335ac9377170c9c | 경흉부심장초음파 (전문) | 20450105 | ============================ 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : chemo 예정 3. Date of Baseline TTE : 2021.07.30 4. Baseline LVEF : 72% 5. Baseline average LV-GLS : -24.6% ============================ 1. Normal c | ||||
0x20454cb4dbb1a52868c08fdec03876a81005d9b833bfb953820abbf973dc8495 | 0x4814ce52b7320d3eae70ce191fc7e01597b03be13499f0dc7b028aa9c594f831 | 경흉부심장초음파 (전문) | 20660613 | 1. Normal sized cardiac chambers with normal LV wall thickness 2. No RWMA with normal LV systolic function(EF=61%). 3. Normal LV diastolic function(septal E/e'=10.9) 4. Normal valves 5. Dilated aortic root (S.valsalva=41mm) Conc.) Normal LV systolic function Dilated aortic root of 41mm | ||||
0x9ed21cda739db906bf3bd4d15ecb78460f0b9c7f0d4a0083fcf6051b17adb400 | 0x8e65624003299a2fe9055520c6002803592e2bc84aecb0e1121e0cd4614a64d2 | 경흉부심장초음파 (단순) | 20571220 | ** S/P ASD device closure(2016.12 | 신촌세브란스) ** s/p ASD percutaneous device closure without remnant shunt by Color Doppler ; LA side disc의 aortic rim부분에 mobile structure가 관찰되며 | 지난 번 검사보다 10mm -> 3.9mm 로 크기가 줄었음. | ||
0x3613abcf73479f2a2ee7bbd1ecd7cfcd224e72ab91983946a08da0727bcdbbc3 | 0xb849a42c1872048a3c919adb7ae8b8e2d4c240180300dd48c4160579a2afa099 | 경흉부심장초음파 (전문) | 20970919 | *very poor echo window* 1. Normal sized cardiac chambers 2. No RWMA with normal LV systolic function (EF = 64%) 3. Normal diastolic function (septal E/e'=8.8 ) 4. Normal valves Conc.) Normal LV systolic function (EF=64%) | ||||
0xbcb45c4875d483af68dfc20ae8ffe564ca9ceff5e12e82bb34ec63284b309da4 | 0xf91368d4ad4fd7c2da010cbc09b4175a6bd20073d63e3040f464636dee8b40ed | 경흉부심장초음파 (전문) | 21000730 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=73%) 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal LV systolic function without RWMA. | ||||
0xe5af7cd05aeaf105be0680b6e11d2891a8e7688c88b350cc344dbaab1de86045 | 0xc2c2114e619383c8948c1e06d4c09368dcefc06bf18e583824d2e099f89ad2d8 | 경흉부심장초음파 (전문) | 20530226 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=55%) 3. Normal LV diastolic function 4. Valves: normal morphology and function | trivial TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | |||
0xe3e6382532baf3e2ca068bf9d30c7c3c697c10fc1ca957279f9d85660724ae9a | 0x9b17ec7af7c89cf2686bb3cab4981521fb2b84effceca6b8b1b6c5f6367e87a3 | 경흉부심장초음파 (전문) | 20530512 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=55%) 3. Normal LV diastolic function 4. Valves: normal morphology and trivial TR 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | ||||
0x47274fd40abb68aead1489da4f67265186e8d21cbe4bfc36275c9a6897d5e919 | 0x9b024edaa69793b17cca6aea7db3ee9690bd40ad1fc1a38a1cf783a4c7bb0b40 | 경흉부심장초음파 (전문) | 20270301 | 1. Slightly small LV dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=71%) 3. Normal LV diastolic function 4. Valves: normal morphology and function | trivial TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc.) Normal LV systolic function (EF=71%) | |||
0xa2eb67d2d3d49c999b9647888566a600756b20640fc2f5c29899222c2eeb6a28 | 0x0e5422440dfe8e0ec6cf62697023e2177bee8b57cba55f39398ea36b35101079 | 경흉부심장초음파 (전문) | 20630904 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=67%) 3. Normal LV diastolic function 4. Valves: normal morphology and function. | trivial TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | |||
0x1489e25284a0fa928e18debcdb648c6c8822aa3b74311ee01f7e82072670ec1b | 0x36d005941c7bfe3a3db7fb0ebee51a0c826ed7d7d714ed4801b0e6f5e8b91e71 | 경흉부심장초음파 (전문) | 20301030 | --------------------------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : #3 HP on 2021.08.02 3. Date of Baseline TTE (2020-11-27) 4. Baseline LVEF : 64% 5. Base | ||||
0xc5cbc4d7cfb4577fcf2dba2178c4d0efe0989915b37e2e8530c442aa7d2b82fb | 0x38b702cbd5a1b0da458ddf967726ba8f6f448560a566c2effa23dc78f0f93c3b | 경흉부심장초음파 (전문) | 21130903 | 1. Normal cardiac dimension with normal LV wall thickness. 2. No RWMA and normal LV systolic function (EF=60%) 3. Normal LV diastolic function. 4. Valves: normal morphology and function | trivial MR and TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | |||
0xe160002201a99f285e83270149b403b8f712ad2b848827a9ed3b32bdc9941325 | 0x6d83438228c25414afa382dde5713e004f64083aa66e56ba6d519adaaec46424 | 경흉부심장초음파 (전문) | 20520805 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=76%) 3. Normal LV diastolic function 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | ||||
0xcbfc2d07c915111b40ce9a0ea715b7b5fd1a61a64a6fa5a7fc8b63eb2517bf9b | 0xfc3028fa2a05ded6ad0eef3957bec8b2ec8a0387d0c9ea2be857b09d44472cda | 경흉부심장초음파 (전문) | 20270624 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=60%) 3. Normal LV diastolic function 4. Valves: normal morphology and function | trivial TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | |||
0x3572b3882221b39d4f4726d2e8aae0786bbf360e14be1622a0f292d521b1f201 | 0xee8bda0bc380aecada933ed3a1bf191f01052c1e79c06a8d000e5a64d16aa125 | 경흉부심장초음파 (전문) | 20961116 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=55%) 3. Normal LV diastolic function (E/e`=7.0 ) 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc.) Normal LV systolic function (EF=55%) | ||||
0xbee6ef85a015734924d31ad290eceb4b9bc43a01675b3db14741524383bbfcce | 0xdcb768e4f0441b88569659d35d76dbaaeb7f7ed8c68b16d361adbb376a3d4005 | 경흉부심장초음파 (전문) | 21050412 | -------------------------------------------------------------------------------------------- 1. Type of cancer: Breast ca. 2. Types of chemotherapy / the number of cycle: #10 Herzuma/perjeta on 2021.10.15 3. Date of Baseline TTE (2020-08-08) 4. Baseline L | ||||
0x1679a662dae036457d53de8979291aa6c4f71d464c8f50debdd5004ad9805405 | 0xfdca964b246d40aa8a1be039d83686137044e90f8bb8bb5fab795868f0579cbc | 경흉부심장초음파 (전문) | 20540120 | ----------------------------------------------------------------------- 1. Type of cancer : r/o lymphoma 2. Types of chemotherapy / the number of cycle : Baseline TTE 3. Date of Baseline TTE (2021.11.04) 4. Baseline LVEF : 68% 5. Baseline average LV-GLS : | ||||
0x3d366b7ca81d74e208731080a71f703675ceb4bfaf874644087fe26a21888fbd | 0x8403feb429d63c7ba696625adf780cb49887a1715e65b4c435f2f9cb7fac0c80 | 경흉부심장초음파 (전문) | 21080118 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=70%) 3. Normal LV diastolic function 4. Valves: normal morphology and function | trivial TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal LV systolic function without RWMA | |||
0x4331e983efdc81ffa7cf017d73fdcbe7c29f95549b7bde4c1835be1a03674875 | 0x8ad2aed6be3a030064eab90d6664ac4e51b7e23b14621a19d14e0ca6ede4c3d9 | 경흉부심장초음파 (전문) | 20230206 | ---------------------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : For Neo CTx / Baseline TTE 3. Date of Baseline TTE (2021-11-08) 4. Baseline LVEF : 65% (57% | ||||
0x8e05bee08d2c262667b7d435dc12fc6c645fedc759fdfafb8bfb0963bd44ec1d | 0xdc72e94784743beda69be9475bdf66a9a6cefb5cbea779b2086281981c50b14b | 경흉부심장초음파 (전문) | 20360423 | ----------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : neo-TCHP / #4 3. Date of Baseline TTE (2022.08.17) 4. Baseline LVEF : 59% 5. Baseline average LV-GLS : | ||||
0x666ba2c49d241b5ee0d3052c8c076895fcf5c6c899dc7f50ab3e9341ce8e9e7d | 0xdd27704029ffc1e324571d6fb001f79e4bddec766d0d3f6257fbe2c9e4d6169a | 경흉부심장초음파 (전문) | 20720116 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=66%) 3. Normal LV diastolic function (E/e`=9.4 ) 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal LV systolic function without RWMA | ||||
0x1e07ca0ab5336558b35f650c3b0f1bd56b938490be6fc9da382f54889fbcfe9f | 0x97cd1e082214ab267c41c49f1fddc2d1232a71f90f303d9d4b38f8d257bb2028 | 경흉부심장초음파 (전문) | 20630509 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=58%) 3. Normal LV diastolic function (E/e`=9.2 ) 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal LV systolic function without RWMA | ||||
0x9ed1a6a7f4991cc8a2acaf2e3d38f869c6f91e88b9fc9547bca2cfc63ac02c78 | 0xad405940dbcafafb4ef6056194380340c5d4ccdbf7a56c182865f4f396eee96c | 경흉부심장초음파 (전문) | 20600520 | ------------------------------------------------------------------------------------- 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : palliative #2.paclitaxel+carboplatin 2022.11.08 3. Date of Baseline TTE: 2020.10.20 4. Ba | ||||
0xdd845e1d9eb7652d1ec5a995a18405ae580b88b04ded45aefdd80b5d39750b60 | 0xf18daee513d1847d4f6b6e88d7a4526c08f324dbfbc1578041eca4f5ab4ff108 | 경흉부심장초음파 (전문) | 20520123 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=59%) 3. Normal LV diastolic function (E/e`=7.5 ) 4. Valves: normal morphology and function. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | ||||
0x1ba7ad56aae5253494dbdfba6dd163dcd8aff5453871ad0d8388a90848bf2279 | 0xa310e1b4b59fabb7ac7bf0687c3da337fa420ab38054935db3799ec1589c6196 | 경흉부심장초음파 (전문) | 20591216 | 1. Normal cardiac dimension with normal LV wall thickness. 2. No RWMA and normal LV systolic function (EF=64%) 3. Normal LV diastolic function (E/e` 9.2) 4. Valves: normal morphology and function | trivial TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Nomral Echocardiography | |||
0x91fb741e654d7634a2847c469354e3e735390aae88ad7514c0ec12bfeafd9b1d | 0xd2d9bcb542cce293437f2806fe99e8fda50e7a64b0913d82ecc567fc51a5962b | 경흉부심장초음파 (전문) | 20390606 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=59%) 3. Normal LV diastolic function (E/e`=6.7 ) 4. Valves: normal morphology and function | trivial MR/TR 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | |||
0x1ffbed35a2de4f98e89be680fa1772d81d9c86ba113ece60f7b6938ac66d12f7 | 0xb1d3ef41588e86433da325948cd4be354a7c0091535fe86c9c6278fb3e6d11e8 | 경흉부심장초음파 (전문) | 20660305 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=75%) 3. Normal LV diastolic function 4. Valves: normal morphology and function | trivial TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal Echocardiography | |||
0x8e32ad56a8f121b4477e74843706f560f77af3ded63c43ea2fb1ef49da233150 | 0x42c8b8cdd5f0dc873665bca683634d85d7d47fc3bd0878397c05962ffbc559c5 | 경흉부심장초음파 (전문) | 20350819 | ========================================= 1. Type of cancer : Breast ca. 2. Types of chemotherapy / the number of cycle : s/p #13 Herceptin CTx. 3. Date of Baseline TTE (2021-02-09) 4. Baseline LVEF : 61% 5. Baseline average LV-GLS : -18.1% ============== | ||||
0xcc8fd0ef5547fe570016d26ddc797cc86c43434b6a14a50bb4a2f08ce5e7f9ff | 0x132d7c0f3b9fb3d307ef3ffb815ebfe4dbbebb5c43bbcc8222466815d84ed143 | 경흉부심장초음파 (전문) | 20280513 | 1. Normal cardiac dimension with normal LV wall thickness 2. No RWMA and normal LV systolic function (EF=55%) 3. Normal LV diastolic function 4. Valves: normal morphology and function | trivial TR. 5. No resting pulmonary hypertension. 6. No pericardial effusion. Conc) Normal LV systolic function without RWMA |
판매제공처 홈페이지 | 판매담당자 | 연락처 | 이메일 |
---|---|---|---|
ypa.or.kr | 용인시산업진흥원 | 031-323-3052 | hwlee@ypa.or.kr |
제약 및 취소/환불 규정 안내 |
---|
데이터 상품은 디지털화된 상품의 특성상 반품, 취소, 환불 되지 않으나 데이터의 심각한 오류, 상이한 데이터에 한하여 구매자가 요구하는 경우 환불을 진행할 수 있습니다. |